NCT04496336View on ClinicalTrials.gov

Non-invasive Substrate Evaluation in Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

February 20, 2020

Primary Completion Date

October 20, 2022

Study Completion Date

November 20, 2022

Conditions
C14.280.067.198
Trial Locations (2)

Unknown

Hospital Gregorio Marañon, Madrid

08036

Hospital Clinic de Barcelona, Barcelona

All Listed Sponsors
collaborator

Gregorio Marañón Hospital

OTHER

lead

Hospital Clinic of Barcelona

OTHER

NCT04496336 - Non-invasive Substrate Evaluation in Atrial Fibrillation | Biotech Hunter | Biotech Hunter